An experimental vaccine made by Sinovac is one of four Chinese candidates in the final stage of clinical trials. China has held preliminary discussions with the WHO to have its vaccines included in a list for emergency use. Photo: AP An experimental vaccine made by Sinovac is one of four Chinese candidates in the final stage of clinical trials. China has held preliminary discussions with the WHO to have its vaccines included in a list for emergency use. Photo: AP
An experimental vaccine made by Sinovac is one of four Chinese candidates in the final stage of clinical trials. China has held preliminary discussions with the WHO to have its vaccines included in a list for emergency use. Photo: AP

Covid-19 vaccine may not be ready until the end of 2021, WHO says

  • That’s the COVAX target for the first 2 billion doses, based on progress of trials in the global scheme, according to official
  • Western Pacific regional coordinator also says China is in talks to have its experimental vaccines assessed for emergency use

Topic |   World Health Organization
An experimental vaccine made by Sinovac is one of four Chinese candidates in the final stage of clinical trials. China has held preliminary discussions with the WHO to have its vaccines included in a list for emergency use. Photo: AP An experimental vaccine made by Sinovac is one of four Chinese candidates in the final stage of clinical trials. China has held preliminary discussions with the WHO to have its vaccines included in a list for emergency use. Photo: AP
An experimental vaccine made by Sinovac is one of four Chinese candidates in the final stage of clinical trials. China has held preliminary discussions with the WHO to have its vaccines included in a list for emergency use. Photo: AP
READ FULL ARTICLE